Despite previous reports of the potential of CIITA gene therapy in brain tumors to induce a potent antitumor immune response, additional control experiments in the same GL261/C57Bl/6 glioma mouse model strongly mitigate the importance of this mechanism. Here, CIITA is linked to brain neoplasm.